Viewing nowCombinationEmpagliflozin/Metformin Hydrochloride 12.5/500 mg (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Aprogen Pharmaceuticals, Co., Ltd.

MFDS item code 202302660 · Approved 2023.09.06 · Insurance code 645211020
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication helps improve blood sugar control in patients with type 2 diabetes by using empagliflozin and metformin together. It is primarily used in adult diabetes patients who are following a diet and exercise regimen. It is especially important to consult a specialist if the patient has a cardiovascular disease and blood sugar is poorly controlled, as there is a risk of cardiovascular events. This medication effectively stabilizes blood sugar levels.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients taking this medicine whose blood glucose is not adequately controlled with metformin alone or in combination with other drugs such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional blood glucose control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dosage adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other symptoms that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, discontinue this medicine immediately (see Precautions for Use, 2. Patients in Whom This Medicine Is Contraindicated, item 2). Elderly patients In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.
This medication is used to treat diabetes and acts to lower blood sugar levels. This drug can cause a rare side effect known as severe lactic acidosis, which can pose a risk to life, so caution is necessary. When used with other diabetes medications, hypoglycemia may occur; thus, attention must be paid to symptoms of low blood sugar. Patients with severely impaired renal function, acute kidney issues, severe infections, acute myocardial infarction, and certain other conditions should not use this medication. Women who are pregnant or breastfeeding should also avoid this medication. Regular kidney function tests should be conducted while on this medication, particularly for elderly patients or those with weak kidney function. If dehydration, severe vomiting, diarrhea, or other conditions arise during treatment, immediate consultation with a doctor is essential, and the medication can be discontinued if necessary. This medication should be discontinued for a certain period before and after undergoing tests using iodine contrast. After confirming recovery of kidney function to normal levels post-testing, resumption can begin. Some patients may experience urinary or genital infections, so they should inform healthcare providers if any infection symptoms arise. B12 vitamin levels may drop, so regular blood tests might be required for patients on prolonged therapy. Alcohol consumption may increase the risk of side effects from this medication, so excessive drinking should be avoided during treatment. This medication poses a risk of hypoglycemia; thus, when used with hypoglycemic agents, attention to low blood sugar symptoms is critical, and dose adjustment of the hypoglycemic agents may be necessary. Patients scheduled for surgery should stop taking the medication 48 hours before the procedure and can resume after verifying normal kidney function post-surgery. Caution should be taken when administering this medication to elderly patients, particularly those over 75 years old, as they may have a higher risk of fluid loss. During treatment, blood sugar control and kidney function should be regularly monitored, and immediate consultation with healthcare providers should occur if abnormal symptoms appear.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to avoid exposure to air or moisture and is best kept at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness and prevent deterioration.
A film-coated tablet that is oval, biconvex, purplish with light brown hue.
60 tablets/box [(10 tablets/PTP x 6)], 10 tablets/box [(10 tablets/PTP x 1)], 30 tablets/bottle, 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Aprogen Pharmaceuticals, Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.